Home/Filings/4/0001171843-17-005225
4//SEC Filing

GOLDENBERG DAVID M 4

Accession 0001171843-17-005225

CIK 0000722830other

Filed

Aug 22, 8:00 PM ET

Accepted

Aug 23, 9:00 PM ET

Size

9.8 KB

Accession

0001171843-17-005225

Insider Transaction Report

Form 4
Period: 2017-08-21
GOLDENBERG DAVID M
DirectorCSO, CMO and Chairman10% Owner
Transactions
  • Sale

    Common Stock

    2017-08-21$8.97/sh20,000$179,4263,475,578 total(indirect: See Footnote)
  • Sale

    Common Stock

    2017-08-22$9.50/sh10,000$95,0003,465,578 total(indirect: See Footnote)
  • Sale

    Common Stock

    2017-08-23$9.50/sh10,000$95,0003,455,578 total(indirect: See Footnote)
Holdings
  • Common Stock

    2,410,489
Footnotes (4)
  • [F1]Includes a total of 635,935 shares held as joint tenants by the reporting person and his spouse, Ms. Cynthia L. Goldenberg, also known as Cynthia L. Sullivan, a director of the Company.
  • [F2]The price in column 4 is a weighted average price. The prices actually received in this transaction range from $8.85 to $9.09.
  • [F3]The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
  • [F4]Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interests therein.

Issuer

IMMUNOMEDICS INC

CIK 0000722830

Entity typeother

Related Parties

1
  • filerCIK 0001029578

Filing Metadata

Form type
4
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 9:00 PM ET
Size
9.8 KB